Deke Medtech Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Later Stage VC
- Investors
-
2
Deke Medtech General Information
Description
Researcher and producer of hydrogel intended for myocardial repair. The company focuses on non-pharmacological treatments, develops the formulation of hydrogel, optimizes treatment protocols, and develops minimally invasive procedures and devices, enabling patients with treatments for end-stage heart failure including cardiac resynchronization pacing (CRT), left ventricular assist devices (LVADs) and heart transplantation.
Contact Information
Website
www.dinovamedtech.comCorporate Office
- Room 340, 3/F, Building 2
- No. 88, Jiangling Road, Binjiang District
- Hangzhou, Zhejiang
- China
Corporate Office
- Room 340, 3/F, Building 2
- No. 88, Jiangling Road, Binjiang District
- Hangzhou, Zhejiang
- China
Deke Medtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Later Stage VC | 14-Feb-2024 | Completed | Generating Revenue |
Deke Medtech Patents
Deke Medtech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4458302-A1 | Adaptive guidance device and transcatheter treatment system | Pending | 31-Dec-2021 | ||
| EP-4458302-A4 | Adaptive guidance device and transcatheter treatment system | Pending | 31-Dec-2021 | ||
| WO-2023125572-A1 | Adaptive guidance device and transcatheter treatment system | Inactive | 31-Dec-2021 | ||
| US-20240350772-A1 | Adaptive guiding device and transcatheter treatment system | Pending | 31-Dec-2021 | ||
| EP-4458291-A1 | Sleeve, injection device, injection system, ablation device and ablation system | Pending | 31-Dec-2021 | A61B18/1492 |
Deke Medtech Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Qiming Venture Partners | Venture Capital | Minority | ||
| Tasly Capital | Corporate Venture Capital | Minority |
Deke Medtech Investments (2)
Deke Medtech’s most recent deal was a Joint Venture with Joint Venture (Deke Medtech / Metronom Health / Ascendum Capital). The deal was made on 18-May-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Joint Venture (Deke Medtech / Metronom Health / Ascendum Capital) | 18-May-2021 | Joint Venture | Monitoring Equipment | ||
| Hangzhou Dinova | Accelerator/Incubator | Therapeutic Devices |
Deke Medtech FAQs
-
When was Deke Medtech founded?
Deke Medtech was founded in 2017.
-
Where is Deke Medtech headquartered?
Deke Medtech is headquartered in Hangzhou, China.
-
What industry is Deke Medtech in?
Deke Medtech’s primary industry is Medical Supplies.
-
Is Deke Medtech a private or public company?
Deke Medtech is a Private company.
-
What is Deke Medtech’s current revenue?
The current revenue for Deke Medtech is .
-
Who are Deke Medtech’s investors?
Qiming Venture Partners and Tasly Capital have invested in Deke Medtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process